Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764190013 | Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3764191012 | Triptorelin (as triptorelin pamoate) 22.5 mg lyophilized powder for suspension for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3786509018 | Triptorelin (as triptorelin pamoate) 22.5 mg lyophilised powder for suspension for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength numerator value (attribute) | 22.5 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | est un(e) (attribut) | Triptorelin only product in parenteral dose form | false | Inferred relationship | Some | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has basis of strength substance (attribute) | Triptorelin (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has precise active ingredient | Triptorelin pamoate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | est un(e) (attribut) | Product containing triptorelin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | a pour principe actif (attribut) | Triptorelin pamoate (substance) | false | Inferred relationship | Some | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | a une forme pharmaceutique (attribut) | Lyophilized powder for conventional release suspension for injection (dose form) | false | Inferred relationship | Some | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | est un(e) (attribut) | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR